Table 1 Patient characteristics among insured and uninsured patients
Insured | Medicaid | Uninsured | ||||||
|---|---|---|---|---|---|---|---|---|
Pre-USPSTF (2010–2012) No. (% or IQR) | Post-USPSTF (2014–2016) No. (% or IQR) | Pre-USPSTF (2010–2012) No. (% or IQR) | Post-USPSTF (2014–2016) No. (% or IQR) | P-valuea | Pre-USPSTF (2010–2012) No. (% or IQR) | Post-USPSTF (2014–2016) No. (% or IQR) | P-valuea | |
Sample size | 124,577 (54.88) | 102,420 (45.12) | 7,351 (47.63) | 8,084 (52.37) | 2,552 (63.15) | 1,489 (36.85) | ||
Median age | 65 (59–71) | 66 (60–72) | 66 (59–73) | 63 (58–70) | 61 (56–64) | 62 (57–67) | ||
PSA, ng/mL | < 0.001 | 0.048 | ||||||
≤ 10 | 83,975 (75.52) | 62,920 (68.69) | 3,285 (53.02) | 3,441 (49.21) | 1,250 (55.07) | 651 (49.28) | ||
10 < PSA ≤ 20 | 15,253 (13.72) | 14,882 (16.25) | 1,224 (19.75) | 1,362 (19.48) | 399 (17.58) | 213 (16.12) | ||
> 20 | 11,969 (10.76) | 13,799 (15.06) | 1,687 (27.23) | 2,189 (31.31) | 621 (27.36) | 457 (34.60) | ||
Total | 111,197 (100.00) | 91,601 (100.00) | 6,196 (100.00) | 6,992 (100.00) | 2,270 (100.00) | 1,321 (100.00) | ||
Biopsy Gleason Score | < 0.001 | 0.004 | ||||||
≤ 6 | 51,845 (45.40) | 32,133 (34.23) | 2,344 (37.41) | 1,966 (28.60) | 823 (36.45) | 399 (31.10) | ||
7 | 43,401 (38.00) | 39,845 (42.45) | 2,364 (37.73) | 2,893 (42.09) | 865 (38.31) | 491 (38.27) | ||
≥ 8 | 18,959 (16.60) | 21,884 (23.32) | 1,557 (24.85) | 2,015 (29.31) | 570 (25.24) | 393 (30.63) | ||
Total | 114,205 (100.00) | 93,862 (100.00) | 6,265 (100.00) | 6,874 (100.00) | 2,258 (100.00) | 1,283 (100.00) | ||
Stage | 0.002 | < 0.001 | ||||||
Localized | 99,138 (81.27) | 75,388 (75.31) | 5,153 (73.61) | 5,199 (66.87) | 1,762 (71.95) | 987 (69.02) | ||
Regional | 17,031 (13.96) | 16,855 (16.84) | 952 (13.60) | 1,230 (15.82) | 350 (14.29) | 186 (13.01) | ||
Distant | 5,813 (4.77) | 7,859 (7.85) | 895 (12.79) | 1,346 (17.31) | 337 (13.76) | 257 (17.97) | ||
Total | 121,982 (100.00) | 100,102 (100.00) | 7,000 (100.00) | 7,775 (100.00) | 2,449 (100.00) | 1,430 (100.00) | ||
Treatment | < 0.001 | 0.524 | ||||||
No local therapy | 64,670 (51.91) | 58,790 (57.40) | 5,089 (69.23) | 5,570 (68.90) | 1,634 (64.03) | 1,041 (69.91) | ||
Prostatectomy and/or radiotherapy | 59,907 (48.09) | 43,630 (42.60) | 2,262 (30.77) | 2,514 (31.10) | 918 (35.97) | 448 (30.09) | ||
Total | 121,982 (100.00) | 100,102 (100.00) | 7,000 (100.00) | 7,775 (100.00) | 2,449 (100.00) | 1,430 (100.00) | ||
Race | < 0.001 | 0.004 | ||||||
White | 87,783 (71.64) | 70,744 (70.03) | 2,570 (35.47) | 3,115 (38.92) | 1,137 (45.15) | 575 (39.36) | ||
Black | 18,268 (14.91) | 15,773 (15.61) | 1,955 (26.98) | 2,265 (28.30) | 766 (30.42) | 543 (37.17) | ||
Hispanic | 10,459 (8.54) | 9,146 (9.05) | 1,791 (24.72) | 1,841 (23.00) | 492 (19.54) | 263 (18.00) | ||
Asian/Pacific Islander | 5,624 (4.59) | 5,015 (4.96) | 873 (12.05) | 715 (8.93) | 119 (4.73) | 78 (5.34) | ||
American Indian/Alaska Native | 396 (0.32) | 335 (0.33) | 56 (0.77) | 67 (0.84) | 4 (0.16) | 2 (0.14) | ||
Total | 122,530 (100.00) | 101,013 (100.00) | 7,245 (100.00) | 8,003 (100.00) | 2,518 (100.00) | 1,461 (100.00) | ||